Live Breaking News & Updates on Umang vohra

Stay informed with the latest breaking news from Umang vohra on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Umang vohra and stay connected to the pulse of your community

WeSkill raises over $400,000 in pre-seed funding round : Tech News

WeSkill raises over $400,000 in pre-seed funding round WeSkill, an online platform that enables live and interactive extracurricular learning for children, has raised more than USD 400K from angel investors and syndicates, as part of its pre-seed round of funding. The round was led by Shrishti Sahu from Swadharma Source Ventures (“SSV”) and was supported

India , Madras , Tamil-nadu , Ahmedabad , Gujarat , Shrishti-sahu , Ritesh-agarwal , Shashank-patidar , Praneet-agarwal , Raj-shastri , Kunal-bahl , Aditya-pittie

Dr Reddy Laboratories : D17 01.41 PR -March 29, 2024 at 05:24 am EDT

Press Release

Dr Reddy's announces the appointment of new Chief Financial Officer

Jan 02, 2009, Hyderabad

Dr. Reddy's...

Hyderabad , Andhra-pradesh , India , Ahmedabad , Gujarat , Russia , Saumen-chakraborty , Nikhil-shah , Umang-vohra , Reddy-umang , Visva-bharati-university-shantiniketan , Ta-pai-institute-of-management

Business News: Cipla Q3 PAT dips 2.6 per cent at Rs 729 crore

Cipla Q3 PAT dips 2.6 per cent at Rs 729 crore : Rashtra News #Cipla #PAT #dips #cent #crore The Mumbai-based company had posted a consolidated profit after tax (PAT) of Rs 748 crore in the October-December quarter of 2020-21 fiscal. Drug major Cipla on Tuesday reported a 2.6 per cent decline in its consolidated

Mumbai , Maharashtra , India , South-africa , United-states , America , Umang-vohra , Cipla , North-america , Business , Cent , Cipla-q3

Cipla gets approval to introduce antibiotic injection to treat UTIs in India

Cipla gets approval to introduce antibiotic injection to treat UTIs in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , United-states , China , Umang-vohra , Medicaid-services , Central-drugs-standard-control-organization , Cipla , Cipla-limited-on , Cipla-limited , Greater-china , Managing-director ,

India pharma companies develop versions of Wegovy to get in on weight-loss windfall

Indian drugmakers are developing their versions of Novo Nordisk's weight-loss treatment, Wegovy, aiming to capitalize on the growing weight-loss market, expected to reach $100 billion a year by the end of the decade. Companies like Sun Pharma, Cipla, Dr Reddy's, and Lupin are working on Wegovy alternatives as Novo Nordisk struggles to meet global demand.

Denmark , India , China , Japan , Danish , Sun-pharma , Vishal-manchanda , Umang-vohra , Nitin-agarwal , Eli-lilly , World-obesity-federation-atlas , Reuters

Sun Pharma, Cipla, Dr Reddy's, Lupin in race for slice of a $100 billion a year pie

Indian pharma companies have started developing their own versions of Novo Nordisk's wildly in demand Wegovy.

Japan , China , India , Denmark , Danish , Umang-vohra , Eli-lilly , Vishal-manchanda , Sun-pharma , Novo-nordisk , Cipla , World-obesity-federation-atlas

Health: India pharma companies develop versions of Wegovy to get in on weight-loss windfall

Health: India pharma companies develop versions of Wegovy to get in on weight-loss windfall
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

China , Japan , Denmark , India , Danish , Eli-lilly , Sun-pharma , Vishal-manchanda , Nitin-agarwal , Umang-vohra , World-obesity-federation-atlas , Cipla

Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand - Novo Nordisk (NYSE:NVO)

Indian pharmaceutical giants, including Sun Pharma and Cipla, seize the opportunity to develop affordable versions of Novo Nordisk's Wegovy weight-loss treatment. With patents set to expire by 2026-2032, these generics aim to address India's rising obesity and diabetes concerns, anticipating substantial market growth in the next decade.

India , Umang-vohra , Vishal-manchanda , Sun-pharma , Novo-nordisk , Cipla , Reddy-laboratories-ltd , Reuters , Expert-market-research , Expert-market ,

India Pharma Companies Develop Versions Of Wegovy to Get in on Weight-loss Windfall

Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions of Novo...

China , India , Denmark , Japan , Hyderabad , Andhra-pradesh , Danish , Dhanya-skariachan , Sun-pharma , Eli-lilly , Rishika-sadam , Nitin-agarwal

Cipla partners with CSIR-CDRI to advance ophthalmic antifungal treatment development

Cipla partners with CSIR-CDRI to advance ophthalmic antifungal treatment development
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Umang-vohra , Industrial-research , Cipla , Cipla-limited-on , Csir-central-drug-research-institute , Council-of-scientific , Cipla-limited , Central-drug-research-institute , Managing-director ,